Zine-Eddine Khene

Dr. Zine-Eddine Khene

Department of Urology, University of Rennes, Rennes, France
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in European Urology
Verified
Journal Article
Closed access
ALAlessandro Larcher
Alessandro Larcher
FMFabio Muttin
Fabio Muttin
BPBenoit Peyronnet
Benoit Peyronnet
GNGeert De Naeyer
Geert De Naeyer
ZKZine-Eddine Khene
Zine-Eddine Khene
AMAlexandre Mottrie
Alexandre Mottrie

11 February 2015 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
ZKZine-Eddine Khene
Zine-Eddine Khene
BPBenoit Peyronnet
Benoit Peyronnet
RMRomain Mathieu
Romain Mathieu
TFTarek Fardoun
Tarek Fardoun
GVGrégory Verhoest
Grégory Verhoest
KBKarim Bensalah
Karim Bensalah

5 March 2018 in BJU International
Verified
Journal Article
Closed access
PDF file
BPBenoît Peyronnet
Benoît Peyronnet
LTLauranne Tondut
Lauranne Tondut
Jean-Christophe BERNHARDJean-Christophe BERNHARD
Jean-Christophe BERNHARD
CVChristophe Vaessen
Christophe Vaessen
NDNicolas Doumerc
Nicolas Doumerc
T(The members of the French Committee of Urologic Oncology (CCAFU)
The members of the French Committee of Urologic Oncology (CCAFU)

23 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
NGNico Christian Grossmann
Nico Christian Grossmann
FSFrancesco Soria
Francesco Soria
TJTristan Juvet
Tristan Juvet
APAaron M. Potretzke
Aaron M. Potretzke
Hooman DjaladatHooman Djaladat
Hooman Djaladat
Benjamin PradereBenjamin Pradere
Benjamin Pradere
Objectives: To identify correlates of survival and perioperative outcomes of upper tract urothelial carcinoma (UTUC) patients undergoing open (ORNU), laparoscopic (LRNU), and robotic (RRNU) radical nephroureterectomy (RNU). Methods: We conducted a retrospective, multicenter study that included non-metastatic UTUC patients who underwent RNU between 1990–2020. Multiple imputation by chained equations was used to impute missing data. Patients were divided into three groups based on their surgical treatment and were adjusted by 1:1:1 propensity score matching (PSM). Survival outcomes per group were estimated for recurrence-free survival (RFS), bladder recurrence-free survival (BRFS), cancer-specific survival (CSS), and overall survival (OS). Perioperative outcomes: Intraoperative blood loss, hospital length of stay (LOS), and overall (OPC) and major postoperative complications (MPCs; defined as Clavien–Dindo > 3) were assessed between groups. Results: Of the 2434 patients included, 756 remained after PSM with 252 in each group. The three groups had similar baseline clinicopathological characteristics. The median follow-up was 32 months. Kaplan–Meier and log-rank tests demonstrated similar RFS, CSS, and OS between groups. BRFS was found to be superior with ORNU. Using multivariable regression analyses, LRNU and RRNU were independently associated with worse BRFS (HR 1.66, 95% CI 1.22–2.28, p = 0.001 and HR 1.73, 95%CI 1.22–2.47, p = 0.002, respectively). LRNU and RRNU were associated with a significantly shorter LOS (beta −1.1, 95% CI −2.2–0.02, p = 0.047 and beta −6.1, 95% CI −7.2–5.0, p < 0.001, respectively) and fewer MPCs (OR 0.5, 95% CI 0.31–0.79, p = 0.003 and OR 0.27, 95% CI 0.16–0.46, p < 0.001, respectively). Conclusions: In this large international cohort, we demonstrated similar RFS, CSS, and OS among ORNU, LRNU, and RRNU. However, LRNU and RRNU were associated with significantly worse BRFS, but a shorter LOS and fewer MPCs.

1 May 2022 in European Urology Focus
Verified
Journal Article
Closed access
ZKZine-Eddine Khene
Zine-Eddine Khene
CMClément Mazouin
Clément Mazouin
ALAlessandro Larcher
Alessandro Larcher
BPBenoit Peyronnet
Benoit Peyronnet
AGAnis Gasmi
Anis Gasmi
KBKarim Bensalah
Karim Bensalah